Stroke Prevention in Reversible Ischemia Trial "SPIRIT"
Completed
Phase 3 ResultsSummary of Purpose
To compare the safety and efficacy of aspirin and oral anticoagulation.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 3 October 2000.
| Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Design
Randomized, open-label, controlled, clinical trial involving 1316 patients at 58 centers.
Contacts
Not available
Recruitment
- Study Size: 1,316
- Number of Centers: 58
- Max Time from Onset: 6 Months
Principal Investigator
-
Dr. Algra
Trial office of the University Department of Neurology, University Hospital Utrecht, Utrecht, The Netherlands
